Researchers have developed a machine learning tool powerful enough to assess an individual's risk of opioid overdose:
of dollars in US healthcare costs and is taking the lives of over 40,000 people in the US in 2017. With health firms reeling from the epidemic's costly consequences, artificial intelligence could offer some light at the end of the tunnel.Researchers developed a machine learning tool that proved to be powerful in assessing overdose risk.
The algorithms accurately identified individuals at high risk of an opioid overdose. The algorithms sorted 560,000 Medicare beneficiaries into risk-based groups. And the machine learning tool's groupings were almost entirely accurate: More than 90% of overdose episodes occurred in the high-risk group.
The AI-powered tool proved a better predictor than traditional methods. For example, the traditional method used by the Centers for Medicare and Medicaid Services classified 70% of people who experienced an overdose as low-risk.AI-powered tools can help health firms to channel their drug abuse spending where it's needed most and curb the opioid epidemic's consequences.
Machine learning could guide health firms to better allocate precious opioid prevention resources to patients who need them most. Three-quarters of beneficiaries were at low risk of experiencing an overdose. Providers and payers could develop more cost-efficient opioid prevention programs by targeting resources at the 25% of patients prescribed opioids who suffer 90% of overdoses.
And targeting opioid prevention resources at high-risk patients could increase the likelihood of preventing costly overdoses. If opioid prevention spending is concentrated among high-risk populations — versus spread out across the population — payers and providers may have a higher chance of preventing overdoses.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
How Machine Learning Can Help Prevent HospitalizationsPreventable hospitalizations are a continuing major problem, and Clover Health is combining tech, health care, and financing to try to reduce them.
Consulte Mais informação »
Machine Learning And AI Are Not The Same: Here's The DifferenceWhen it comes to Big Data, these computer science terms are often used interchangeably, but they are not the same thing. While it may sound confusing, it is actually simple to differentiate the terms when you understand how they work together. Here is the difference between AI and Machine Learning
Consulte Mais informação »
Sugary drink regulations to help curb childhood obesity supported by pediatricians group, American Heart AssociationTwo of the nation’s most prominent health organizations have issued a joint policy statement calling for additional taxes across the U.S. on sugary beverages and limits on marketing to children.
Consulte Mais informação »
How garden-based learning helps students of color'When we thoughtfully create spaces for educators to connect students to natural history on their campus, we’re fostering stewardship and a curiosity about life science and the natural world.' - NBCLatino
Consulte Mais informação »
Tate galleries to stop accepting donations from Sackler family amid opioid crisisThe UK's Tate galleries will no longer accept donations from the Sackler family, whose company is accused of contributing to the opioid crisis in the US by aggressively marketing OxyContin while denying its association with overdose and death
Consulte Mais informação »
Guggenheim Museum will no longer accept gifts from Sackler family, makers of opioid OxyContin
Consulte Mais informação »
OxyContin-maker Purdue Pharma and Sackler family agree to pay $270 million to settle opioid caseThe case against Purdue and other manufacturers was scheduled to go to trial in May. Accusations against the Stamford, Connecticut-based company included downplaying the addiction risk of opioids while overstating the benefits.
Consulte Mais informação »
Purdue Pharma agrees to $270M opioid settlement with OklahomaPurdue Pharma, the OxyContin maker accused of helping to spark and fuel the nation’s opioid epidemic, has reportedly agreed to pay $270 million to settle a lawsuit with Oklahoma
Consulte Mais informação »
OxyContin maker Purdue reaches $270 million settlement in Oklahoma opioid case: sourcePurdue Pharma LP and members of the wealthy Sackler family that own the OxyConti...
Consulte Mais informação »